Cesium potentiates epileptiform activities induced by bicuculline methiodide in rat neocortex maintained in vitro

Epilepsia. 1991 Nov-Dec;32(6):747-54. doi: 10.1111/j.1528-1157.1991.tb05529.x.

Abstract

We report that extracellular application of cesium (Cs+, 3 mM) potentiated the epileptiform discharge evoked by GABAA-receptor antagonist bicuculline methiodide (BMI 50 microM) in rat neocortical slices maintained in vitro. Cs+ changed BMI-induced epileptiform burst of a few hundred milliseconds evoked by extracellular focal stimuli into epileptiform discharge only a few seconds long (1.8-7 s). Moreover, Cs+ induced the appearance of spontaneously occurring epileptiform activities (0.038-0.15 Hz). Simultaneous intracellular/extracellular recordings indicated that each intracellular epileptiform burst was correlated with a field discharge. Variation of the membrane potential modified only the amplitude of the epileptiform burst and did not alter its frequency of occurrence, indicating that each discharge was a synchronous population event. The epileptiform discharges were not blocked by the N-methyl-D-aspartate (NMDA) receptor antagonist 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP 5-10 microM). In contrast, the non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX 0.5-5 microM) greatly reduced the duration of each epileptiform discharge by abolishing its afterdischarges in a concentration-dependent manner. This reduction in duration was accompanied by an increase in frequency of occurrence, however. After blockade of non-NMDA receptors with CNQX, a CPP-sensitive spontaneous discharge could be observed. These findings indicate that the inorganic cation Cs+ applied extracellularly can induce spontaneously occurring epileptiform activities in BMI-treated neocortical slices. In addition, receptors of excitatory amino acids play a major role in synchronizing this type of Cs+/BMI-induced spontaneous epileptiform activities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 6-Cyano-7-nitroquinoxaline-2,3-dione
  • Action Potentials / drug effects
  • Animals
  • Anticonvulsants / pharmacology
  • Bicuculline / analogs & derivatives*
  • Bicuculline / pharmacology
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / physiopathology
  • Cesium / pharmacology*
  • Drug Synergism
  • Electroencephalography* / drug effects
  • Epilepsies, Partial / chemically induced*
  • Epilepsies, Partial / physiopathology
  • In Vitro Techniques
  • Male
  • Piperazines / pharmacology
  • Quinoxalines / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Receptors, GABA-A / drug effects

Substances

  • Anticonvulsants
  • Piperazines
  • Quinoxalines
  • Receptors, GABA-A
  • Cesium
  • bicuculline methiodide
  • 6-Cyano-7-nitroquinoxaline-2,3-dione
  • 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
  • Bicuculline